OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Alzheimer’s disease (AD) is the leading cause of dementia worldwide, with no cure currently available. AD pathogenesis is primarily driven by cerebral accumulation of β-amyloid (Aβ), a small peptide and proteolytic cleavage product of amyloid-β precursor protein (APP). Elucidating molecular mechanisms that change Aβ levels and APP processing could provide new insights for understanding disease etiology; and development of interventions that attenuate amyloid pathology may provide useful therapeutics for AD.
